SCHEMBL3287845

SCHEMBL3287845

CC1(C)[C@@H](C(=O)O)[C@@H]1c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 6/20 0.62
EDNRA P25101 1/20 0.39
HDAC4 P56524 2/20 0.39
HTT P42858 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATM Q13315 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RECQL P46063 1/20 0.38
LMNA P02545 2/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3287838 1.00 SLC9A1 (0.62) SLC9A1EDNRAHDAC4HTTCYP1A2
SCHEMBL3655655 1.00 SLC9A1 (0.62) SLC9A1EDNRAHDAC4HTTCYP1A2
SCHEMBL3287837 1.00 SLC9A1 (0.62) SLC9A1EDNRAHDAC4HTTCYP1A2
SCHEMBL16819920 1.00 SLC9A1 (0.62) SLC9A1EDNRAHDAC4HTTCYP1A2
Hydrochloric Acid SCHEMBL11009588 0.98 SLC9A1 (0.60) SLC9A1EDNRAHDAC4HTTCYP1A2
SCHEMBL18927360 0.88 SLC9A1 (0.62) SLC9A1HTTCYP1A2CYP3A4CYP2D6
SCHEMBL14276417 0.84 SLC9A1 (0.66) SLC9A1HTTMEN1KMT2AALDH1A1
SCHEMBL2393407 0.84 SLC9A1 (0.68) SLC9A1HTTCYP1A2CYP3A4CYP2D6
SCHEMBL3288310 0.84 SLC9A1 (0.68) SLC9A1HTTCYP1A2CYP3A4CYP2D6
SCHEMBL3287377 0.84 SLC9A1 (0.46) SLC9A1HDAC4HTTMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793821-B2 Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME LLC (US) 2023-10-24 US disclosed
CN-109153649-B Allosteric modulators of nicotinic acetylcholine receptors 默沙东公司 2022-04-19 CN disclosed
EP-3433234-B1 ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME (US) 2021-10-27 EP disclosed
US-20210196734-A1 SUBSTITUTED 6-MEMBERED ARYL OR HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2021-07-01 US disclosed
US-11026958-B2 Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME CORP. (US) 2021-06-08 US disclosed
US-20210077511-A1 SUBSTITUTED 6-MEMBERED ARYL OR HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2021-03-18 US disclosed
US-10870630-B2 Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME CORP. 2020-12-22 US disclosed
US-20190337910-A1 ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2019-11-07 US disclosed
US-20190308945-A1 SUBSTITUTED BICYCLIC HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2019-10-10 US disclosed
EP-2888229-B1 alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF MERCK SHARP & DOHME (US) 2019-02-06 EP disclosed
US-20150175534-A1 Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-I MERCK SHARP & DOHME CORP. 2015-06-25 US disclosed
US-20150175534-A1 Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-I MERCK SHARP & DOHME CORP. 2015-06-25 US disclosed
US-20150175534-A1 Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-I MERCK SHARP & DOHME CORP. 2015-06-25 US disclosed
US-9062013-B2 Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof BIONOMICS LIMITED (AU) 2015-06-23 US disclosed
EP-2207540-B1 CYCLOPROPYL ARYL AMIDE DERIVATIVES AND USES THEREOF HOFFMANN LA ROCHE (CH) 2014-02-26 EP disclosed
US-20140031395-A1 Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and uses Thereof BIONOMICS LIMITED (AU) 2014-01-30 US disclosed
CN-101815512-B Cyclopropyl aryl amide derivatives and uses thereof HOFFMANN LA ROCHE 2013-04-24 CN disclosed
CN-101815512-A cyclopropyl aryl amide derivatives and uses thereof HOFFMANN LA ROCHE 2010-08-25 CN disclosed
US-7723391-B2 Cyclopropyl aryl amide derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2010-05-25 US disclosed
US-20090093525-A1 Cyclopropyl aryl amide derivatives and uses thereof ROCHE PALO ALTO LLC 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190337910-A1 ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA6 SLC9A1 3871/4885EDNRA 714/4885HDAC4 3232/4885
US-11793821-B2 Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors CHRNA7, CHRNA6, CHRNA5 SLC9A1 4534/4885EDNRA 1282/4885HDAC4 3362/4885
US-10870630-B2 Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 SLC9A1 4394/4885EDNRA 1123/4885HDAC4 3722/4885
US-20150175534-A1 Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-I CHRNA7, CHRNA6, CHRNA5 SLC9A1 2670/4885EDNRA 1144/4885HDAC4 3140/4885
US-11026958-B2 Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors CHRNA7, CHRNA6, CHRNA5 SLC9A1 4518/4885EDNRA 1256/4885HDAC4 3241/4885
US-20210196734-A1 SUBSTITUTED 6-MEMBERED ARYL OR HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA6, CHRNA5 SLC9A1 4534/4885EDNRA 1282/4885HDAC4 3362/4885
US-20210077511-A1 SUBSTITUTED 6-MEMBERED ARYL OR HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA6, CHRNA5 SLC9A1 4391/4885EDNRA 1295/4885HDAC4 3420/4885
US-20140031395-A1 Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and uses Thereof CHRNA7, CHRNA5, CHRNA10 SLC9A1 2810/4885EDNRA 763/4885HDAC4 1298/4885
US-20090093525-A1 Cyclopropyl aryl amide derivatives and uses thereof AR, ADRA2A, ADRA1A SLC9A1 3094/4885EDNRA 268/4885HDAC4 844/4885
US-20190308945-A1 SUBSTITUTED BICYCLIC HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA2 SLC9A1 4394/4885EDNRA 1123/4885HDAC4 3722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.